# Celanese Corp: Form 10-K for the period ended Dec 31, 2017

- Company: [Celanese Corp](/companies/ce.md) (CIK 1306830)
- Form: 10-K
- Filed: 2018-02-09
- Accepted by EDGAR: Feb 9, 2018, 16:28 ET
- Period: 2017-12-31
- Accession: 0001306830-18-000030
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1306830/000130683018000030/ce-20171231x10k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1306830/000130683018000030/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 12 months, 2017-01-01 to 2017-12-31 | $4.63bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2017-01-01 to 2017-12-31 | $1.51bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2017-01-01 to 2017-12-31 | $72.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2017-01-01 to 2017-12-31 | $456.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2017-01-01 to 2017-12-31 | $901.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2017-01-01 to 2017-12-31 | $122.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2017-01-01 to 2017-12-31 | $213.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2017-01-01 to 2017-12-31 | $843.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2017-01-01 to 2017-12-31 | $6.09 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2017-01-01 to 2017-12-31 | $6.11 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2017-01-01 to 2017-12-31 | 138,317,395 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2017-01-01 to 2017-12-31 | $803.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2017-01-01 to 2017-12-31 | $267.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2017-01-01 to 2017-12-31 | $241.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2017-01-01 to 2017-12-31 | $500.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-12-31 | $576.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-12-31 | $2.79bn | us-gaap:AssetsCurrent |
| Total assets | at 2017-12-31 | $9.54bn | us-gaap:Assets |
| Current liabilities | at 2017-12-31 | $1.56bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2017-12-31 | $3.31bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2017-12-31 | $326.0m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2017-12-31 | $2.89bn | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1306830/000130683018000030/ce-20171231x10k.htm

Filed Feb 9, 2018.
Source: SEC EDGAR, the filing index for accession 0001306830-18-000030. Last ingested by Listed: Nov 13, 2026, 16:24 ET. No prices; not investment advice.
